WB and IHC analysis of subcutaneous tumor tissues in the CDX and PDX models showed that TMEM160 knockdown reduced the expression of NRF2 and its target genes, GPX4 and SLC7A11 (Fig. 7E, F, J, and K). This evidence concerns the gene GPX4 and neoplasm.